Breast Reconstruction Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

Breast Reconstruction Market Size

Breast Reconstruction Market Trends & Growth Drivers

Growing Popularity of Aesthetic Procedures in Developing Countries Is Key Trend

• A key trend in the market is the growing popularity of breast implants as an aesthetic procedure in emerging economies.
• As the concept of the ideal body shape gains in more focus in LATAM, APAC, and the MEA, driven by the influence of the Western culture propagated by social media, TV, and fashion magazines, women in these regions are becoming conscious of how they look.
• Since ample breasts are portrayed as being desirable in society, more women in the region are going for breast augmentation for purely aesthetic purposes.
• This is enabled by the rising disposable income in these nations as more females join the workforce.
• As per the International Society of Aesthetic Plastic Surgery, 1,892,777 breast augmentations were conducted globally in 2023.
• Moreover, among the five most-common procedures among women were breast augmentation and breast lift.
• The numbers for breast augmentation procedures in Brazil were 551,153 in 2023 and 542,970 in 2022.
• Similarly, in India, the numbers stood at 129,818 in 2023 and 89,153 in 2022.

High Prevalence of Breast Cancer Will Drive the Market

• Breast cancer is usually detected among women and is treated using mastectomy, in which the entire breast is removed with a surgical process.
• Breast reconstruction surgeries are used to rebuild the breasts after the removal of natural breasts.
• Implant reconstruction and autologous or flap reconstruction are the two main techniques used in these surgeries.
• With the rising prevalence of breast cancer worldwide, women are opting for reconstruction procedures to regain the natural shape of their breasts after the mastectomy.
• Moreover, breast cancer is the most commonly diagnosed cancer among women, registering 2,296,840 new diagnoses in 2022, as per the World Cancer Research Fund International.
• As per breastcancer.org, it accounts for almost 30% of the cancer cases in women in the U.S.
• Almost 85% of the cases are diagnosed in women with no family history of this disease, with the condition governed by their genetics instead.
• Hence, the increasing prevalence of breast cancer, coupled with the growing preference for breast reconstruction procedures, is expected to support the market growth.

3D-Printed Implants Are Major Opportunity Area

• A major opportunity for the breast reconstruction market is 3D-printed implants.
• The technique involves feeding data on the anatomy of a woman’s natural breasts into a computer and then creating a digital model on CAD software.
• The data, along with the choice of material, such as silicone, saline, or the woman’s own fatty tissue, is fed to a 3D printer, to create the product.
• For instance, Lattice Medical is developing a tissue-regrowing implant, known as Mattise.
• It uses a bioabsorbable shell that is designed to resemble the desired breast shape.
• The shell is filled with healthy tissue taken from the person, which grows inside the shell and takes the shape of the natural breast.
• The shell slowly decades, leaving behind the regrown implant.
• Similarly, in a recent procedure, University of East Anglia (UEA) in Norwich used a 3D printer to create a mold for the implant to be used in breast reconstruction.

Breast Reconstruction Market Analysis

Product Type Insights

In 2024, the breast implants category holds the largest market share, of 55%. Because of the reduced surgical duration and lack of donor sites, patients usually prefer implants in the breast reconstructing process.

In addition, many women choose reconstruction operations to restore the natural shape of their breasts. This is mostly due to the rising prevalence of breast cancer in developing nations such as China, India, and South Africa. This helps the market for implants to grow in the coming years.

The tissue expanders category will likely have the highest CAGR, of 6.7%, during the forecast period. This is credited to the advantages of these products for women undergoing breast reconstruction, such as quick, simple, and cost-effective procedure. Additionally, several such products have received the regulatory approval in recent years, which continues to drive their popularity.

The following product types are considered in the report:

• Breast Implants (Largest Category)
• Tissue Expanders (Fastest-Growing Category)
• Acellular Dermal Matrix (ADM)
• Others

Procedure Insights

The immediate procedure category continues holds the largest revenue share in the breast reconstruction market, of 45%, in 2024. It is also the fastest-growing category, with a CAGR of 6.8%, during this decade.

The immediate procedure includes a quicker recovery, low cost, more natural appearance, and less noticeable scarring. After the removal of the breast, a surgeon initiates the reconstruction process of the breast either with tissue from another location of the body or with an implant. Usually, patients prefer the immediate process after mastectomy, as it allows them to avoid multiple surgeries and less downtime, while eliminating further surgeries in the future.

The report offers insights on the below-mentioned procedures:

• Immediate (Largest and Fastest-Growing Category)
• Delayed
• Revision

Placement Insights

The dual-plane insertion category accounts for the largest market share, and it will also witness the highest CAGR, during the forecast period. This technique assists breast implants to sit in the most natural position and adjusts them to ensure adequate soft-tissue coverage. The placement offers more benefits and fewer complications as compared to a single-pocket location. This allows the breast gland to cover properly the new mound created by the implant under the muscle. The method has a 24-hour recovery time and is less painful.

We have studied these placements in the report:

• Dual Plane Insertion (Largest and Fastest-Growing Category)
• Subglandular Insertion
• Submuscular Insertion

End User Insights

Hospitals dominate the market in 2024, with 70% share, as they are the preferred places for people to get surgeries. Moreover, since despite the development of minimally invasive techniques, breast surgeries involve a significant degree of invasion, most people choose hospitals because of their better infrastructure, trained professionals, and comprehensive pre- and post-operative care.

Cosmetology clinics and ambulatory surgical centers will grow faster, at 6.6% CAGR, during 2024–2030. This is attributed to the increasing accessibility around the world and their cost-effectiveness over full-fledged hospitals. ASCs also offer shorter waiting times and, often, faster procedure. Moreover, these medical centers are rapidly adopting minimally invasive and robotic surgical techniques, thus boosting trust among patients.

The report covers the following end users:

• Hospitals (Largest Category)
• Cosmetology Clinics and Ambulatory Surgical Centers (Fastest-Growing Category)

Regional Analysis

• North America is expected to lead the overall breast reconstruction market throughout the forecast period, with a revenue share of around 40% in 2030.
• The surging incidences of breast cancer, increasing breast augmentation procedures, and established healthcare infrastructure are some of the key factors accountable for the largest market share.
• Also, governments are focusing on the implementation of various programs to spread awareness about the implant procedure, which, in turn, drives the demand for breast reconstruction in North America.
• In recent years, the U.S. FDA has approved a large number of products related to implant procedures.
• APAC is expected to have the highest CAGR, of 7.0%, during the forecast period.
• This is attributed to the increasing incidence of breast cancer in regional countries, with the top countries being Pakistan, Singapore, and the Philippines.
• In India, breast cancer is the most common of all cancers in India, accounting for over 28% of all cancer cases in women and a total of 216,108 in 2022.
• Almost half the cases are diagnosed in women in the age group of 25 to 50 years, and almost 70% of all the cases have poor survivability on account of being in the advanced stages.
• Other reasons for the rapid growth forecast in APAC region are the increasing awareness of the breast augmentation procedures available, rising disposable income of women, their surging consciousness about their appearance, growing medical tourism industry, and advancing medical infrastructure with the adoption of surgical robots.
• In Europe, the German market contributes the highest revenue.
• The key factors contributing to the growth of the market include the increasing awareness about reconstruction procedures, technological advancement, and the rising prevalence of breast cancer, across the world.
• The U.K. accounts for the fastest-growing market in the region.
• Breast enlargement surgery is one of the most regularly performed procedures in the country and involves the insertion of implants under the breast tissue to increase the size or change the shape of the breasts.
• Furthermore, favorable government policies in the U.K. are expected to increase breast cancer awareness among the population, which, in turn, is likely to drive the market growth in the coming years.

The report contains analysis for the following regions and countries:

• North America (Largest Regional Market)
  • U.S. (Larger and Faster-Growing Country Market)
  • Canada
• Europe
  • U.K. (Fastest-Growing Country Market)
  • Germany (Largest Country Market)
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • India (Fastest-Growing Country Market)
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa (Fastest-Growing Country Market)
  • Rest of MEA

Breast Reconstruction Market Share

The breast reconstruction market is fragmented primarily due to the availability of wide-ranging surgical techniques and implantable products. Additionally, a lot of established companies operate around the world, following disruptive strategies to enhance their presence and share. Further, these companies market increasingly technologically advanced and customizable products.

Breast Reconstruction Market News

• In May 2024, Bimini Health Tech received the FDA approval for its Puregraft Serene breast implants. Serene is a line of structured saline implants, while Puregraft is a brand of fat transfer products.
• In November 2023, RTI Surgical Holdings announced the receipt of the FDA’s IDE approval for a study aimed at ascertaining the effectiveness of yjr Cortiva allograft dermis in breast reconstruction.
• In October 2023, CG Aesthetics announced a partnership with Bimini Health Tech, under which CG Aesthetics will offer Bimin’s breast reconstruction products outside the U.S. and Canada, while Bimini will do the same for DG Aesthetics in the U.S.